Manulife (Manufacturers Life Insurance)
LXRX icon

Manulife (Manufacturers Life Insurance)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-29,646
Closed -$21.9K – 2956
2024
Q4 		$21.9K Sell
29,646
-18,402
-38% -$22.2K ﹤0.01% 2959
2024
Q3 		$75.4K Sell
48,048
-1,909
-4% -$3.4K ﹤0.01% 2931
2024
Q2 		$83.9K Buy
49,957
+14,411
+41% +$25.9K ﹤0.01% 2866
2024
Q1 		$85.3K Buy
35,546
+17,326
+95% +$37.2K ﹤0.01% 2815
2023
Q4 		$27.9K Sell
18,220
-24,267
-57% -$28.9K ﹤0.01% 2928
2023
Q3 		$46.3K Buy
42,487
+1,319
+3% +$2.31K ﹤0.01% 2946
2023
Q2 		$94.3K Buy
41,168
+5,225
+15% +$13.9K ﹤0.01% 2868
2023
Q1 		$87.3K Hold
35,943
– – ﹤0.01% 2771
2022
Q4 		$68.7K Buy
35,943
+20,065
+126% +$42.7K ﹤0.01% 2875
2022
Q3 		$38.1K Buy
+15,878
New +$43.9K ﹤0.01% 2926
2022
Q2 		– Sell
-33,729
Closed -$70.5K – 3081
2022
Q1 		$70.5K Sell
33,729
-5,611
-14% -$15.6K ﹤0.01% 3008
2021
Q4 		$155 Buy
39,340
+270
+0.7% +$1.31K ﹤0.01% 2978
2021
Q3 		$188K Sell
39,070
-2,455
-6% -$10.1K ﹤0.01% 3008
2021
Q2 		$191K Buy
41,525
+10,151
+32% +$48.9K ﹤0.01% 3131
2021
Q1 		$184K Sell
31,374
-469
-1% -$3.25K ﹤0.01% 2926
2020
Q4 		$109K Buy
+31,843
New +$60.7K ﹤0.01% 2945
2020
Q2 		– Sell
-31,248
Closed -$61K – 2893
2020
Q1 		$61K Buy
31,248
+2,396
+8% +$7.13K ﹤0.01% 2697
2019
Q4 		$120K Sell
28,852
-1,597
-5% -$6.15K ﹤0.01% 2752
2019
Q3 		$105K Buy
30,449
+346
+1% +$1.07K ﹤0.01% 2815
2019
Q2 		$189K Sell
30,103
-2,047
-6% -$12.3K ﹤0.01% 2676
2019
Q1 		$179K Buy
32,150
+3,191
+11% +$19.4K ﹤0.01% 2469
2018
Q4 		$192K Sell
28,959
-3,165
-10% -$25.6K ﹤0.01% 2339
2018
Q3 		$343K Sell
32,124
-3,686
-10% -$42.2K ﹤0.01% 2481
2018
Q2 		$430K Sell
35,810
-373
-1% -$3.81K ﹤0.01% 2506
2018
Q1 		$310K Buy
36,183
+124
+0.3% +$1.15K ﹤0.01% 2699
2017
Q4 		$356K Buy
36,059
+662
+2% +$6.88K ﹤0.01% 2558
2017
Q3 		$436K Sell
35,397
-1,020
-3% -$15.1K ﹤0.01% 2371
2017
Q2 		$599K Buy
36,417
+1,291
+4% +$20K ﹤0.01% 2151
2017
Q1 		$505K Buy
35,126
+3,712
+12% +$55.1K ﹤0.01% 2178
2016
Q4 		$435K Buy
31,414
+146
+0.5% +$2.34K ﹤0.01% 2193
2016
Q3 		$565K Sell
31,268
-659
-2% -$10.6K ﹤0.01% 1992
2016
Q2 		$458K Buy
31,927
+1,970
+7% +$26.7K ﹤0.01% 2093
2016
Q1 		$368K Sell
29,957
-596
-2% -$6.25K ﹤0.01% 2173
2015
Q4 		$407 Hold
30,553
– – ﹤0.01% 2146
2015
Q3 		$329 Sell
30,553
-88
-0.3% -$961 ﹤0.01% 2268
2015
Q2 		$247 Buy
30,641
+4,622
+18% +$33.9K ﹤0.01% 2688
2015
Q1 		$172 Buy
26,019
+1,397
+6% +$9.54K ﹤0.01% 2851
2014
Q4 		$157 Buy
24,622
+1,794
+8% +$14.5K ﹤0.01% 2821
2014
Q3 		$225 Buy
22,828
+276
+1% +$2.95K ﹤0.01% 2567
2014
Q2 		$254K Sell
22,552
-3,747
-14% -$40.2K ﹤0.01% 2543
2014
Q1 		$318 Buy
26,299
+356
+1% +$4.55K ﹤0.01% 2391
2013
Q4 		$326 Buy
25,943
+2
+0% +$32 ﹤0.01% 2357
2013
Q3 		$431 Sell
25,941
-1,270
-5% -$21.3K ﹤0.01% 2083
2013
Q2 		$413K Buy
+27,211
New +$413K ﹤0.01% 2016

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s LXRX Position: Q1 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2025, closing a stake of 29,646 shares — an estimated $21.9K sold.

Manulife (Manufacturers Life Insurance) first reported a position in LXRX in Q2 2013 and held it in 44 quarters. The position peaked at $599K in Q2 2017. 127 funds tracked by Wall St. Rank hold LXRX as of Q1 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Lexicon Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 29,646 Lexicon Pharmaceuticals shares in Q1 2025, an estimated $21.9K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 44 quarters.
  • Manulife (Manufacturers Life Insurance)'s Lexicon Pharmaceuticals position peaked at $599K in Q2 2017.
  • 127 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2025, filed 15 May 2025.